I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
These trials are currently being conducted at the Johns Hopkins Department of Radiation Oncology and Molecular Radiation Sciences. If you would like to find out more about clinical trials and how they work, you can read about them on our About Clinical Trials page.
To learn more about trials being conducted at Johns Hopkins and how to enroll in a trial, contact:
Shirl DiPasquale, RN, MS, OCN
(For trials treating cancers of the breast, lung, and prostate)
Kelly Szajna, RN, BS
(For trials treating cancers of the central nervous system, breast, lung, and prostate)
Explore the full listing of cancer-related clinical trials at the Sidney Kimmel Cancer Center.
Z15111 - Exploratory Study of the CytoRADx System as a Biodosimeter
Brain and Central Nervous System
J11120 - A phase II trial of low dose fractionated radiation therapy as a chemo-potentiator of salvage temozolomide for recurrent anaplastic astrocytoma and glioblastoma multiforme
J1426 - A Randomized Phase II Study of Subventricular Zone (SVZ) Irradiation Plus Temozolomide in Newly Diagnosed Glioblastoma Multiforme
J1737 - Preservation of Cognition and Neuropsychiatric Functioning with Corpus Callosum Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases: A Pilot Study
J14106 - Non-invasive Detection of Cancer DNA in Blood and Urine
R0926 - A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging
J13104 - A Randomized Phase II Study of Partial Breast Irradiation and Sequential vs. Concurrent Chemotherapy in Women with ER Negative Early Stage Breast Cancer (PBI 3.0)
J1564 - The IDEA Study (Individualized Decisions for Endocrine therapy Alone): A prospective, single-arm cohort study of patients receiving endocrine therapy alone (without radiotherapy) after breast conserving surgery for early-stage, post-menopausal breast cancer patients whose tumors have favorable biologic features.
J1660 - A Clinical Trial To Evaluate Image-Guided Gynecologic Brachytherapy In The MR Simulator Suite
Head and Neck
J14191 - A Feasibility Study of the VibrentTM Smartphone App for Head & Neck Cancer Patients: Supporting Pain Management of Radiation-Induced Mucositis
J15183 - A Phase II Trial of Reirradiation Combined with Open Label MK-3475 (Pembrolizumab) in Patients with Locoregional Inoperable Recurrence or Second Primary Squamous Cell Carcinoma of the Head and Neck (SCCHN)
J12133 - Phase II Study of Post-Operative Stereotactic Radiosurgery for Solid Tumor Spine Metastases
J1367 - A Phase II Study of Hypofractionated Stereotactic Radiotherapy in the Treatment of Metastatic Pediatric Sarcomas of Bony Sites
J1273 - Phase II Study to Evaluate Stereotactic Body Radiation Therapy For Palliative Management of Unresectable Recurrent or Residual Pancreatic or Periampullary Adenocarcinoma
J15237 - A Phase II Study of GM-CSF secreting allogeneic pancreatic cancer vaccine in combination with PD-1 Blockade Antibody (Pembrolizumab) and Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with Locally Advanced Adenocarcinoma of the Pancreas
J0859 - Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
J1192 - A Randomized Controlled Trial of Prostatak as Adjuvant to Up-Front Radiation Therapy for Localized Prostate Cancer
J11143 - Multiparametric MRI for assessing radiotherapy treatment response of prostate cancer
J11157 - Stereotactic Body Radiation Therapy and Short-Term Androgen Ablation for Intermediate-Risk, Localized, Adenocarcinoma of the Prostate
J1454 - Phase II Randomized Placebo-Controlled Double-Blind Study of Salvage Radiation Therapy (SRT) Plus Placebo Versus SRT Plus Enzalutamide in Men with High-Risk PSA-Recurrent Prostate Cancer after Radical Prostatectomy
J15180 - Phase II Randomized Observation versus Stereotactic Ablative RadiatIon for OLigometastatic Prostate CancEr (ORIOLE) Trial
J14187 - REASSURE - Radium-223 alpha Emitter Agent in Safety Study in mCRPC population for long-term Evaluation
J15203 - Pilot Biomarker Study of Stereotactic Body Radiation Therapy for Prostate Cancer Oligometastases
Request an Appointment
Already a Patient?
Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.